Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95,490,450
-
Total 13F shares
-
14,008,673
-
Share change
-
-1,177,979
-
Total reported value
-
$27,590,926
-
Put/Call ratio
-
21%
-
Price per share
-
$1.97
-
Number of holders
-
31
-
Value change
-
-$2,313,872
-
Number of buys
-
8
-
Number of sells
-
13
Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q2 2023
As of 30 Jun 2023,
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,008,673 shares.
The largest 10 holders included
Long Focus Capital Management, LLC, Bpifrance SA, Capital International Investors, CREDIT SUISSE AG/, BAILLIE GIFFORD & CO, MILLENNIUM MANAGEMENT LLC, PRINCIPAL FINANCIAL GROUP INC, MACQUARIE GROUP LTD, KBC Group NV, and OPPENHEIMER & CO INC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.